LOVFF
Price
$1.29
Change
-$0.00 (-0.00%)
Updated
Oct 3 closing price
Capitalization
117.53M
TSMRF
Price
$23.20
Change
-$1.83 (-7.31%)
Updated
Aug 25 closing price
Capitalization
1.79B
Interact to see
Advertisement

LOVFF vs TSMRF

Header iconLOVFF vs TSMRF Comparison
Open Charts LOVFF vs TSMRFBanner chart's image
Cannara Biotech
Price$1.29
Change-$0.00 (-0.00%)
Volume$300
Capitalization117.53M
Tsumura & Co
Price$23.20
Change-$1.83 (-7.31%)
Volume$400
Capitalization1.79B
LOVFF vs TSMRF Comparison Chart in %
LOVFF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
TSMRF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
LOVFF vs. TSMRF commentary
Oct 04, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is LOVFF is a Buy and TSMRF is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Oct 04, 2025
Stock price -- (LOVFF: $1.29 vs. TSMRF: $23.20)
Brand notoriety: LOVFF and TSMRF are both not notable
Both companies represent the Pharmaceuticals: Generic industry
Current volume relative to the 65-day Moving Average: LOVFF: 6% vs. TSMRF: 134%
Market capitalization -- LOVFF: $117.53M vs. TSMRF: $1.79B
LOVFF [@Pharmaceuticals: Generic] is valued at $117.53M. TSMRF’s [@Pharmaceuticals: Generic] market capitalization is $1.79B. The market cap for tickers in the [@Pharmaceuticals: Generic] industry ranges from $64.92B to $0. The average market capitalization across the [@Pharmaceuticals: Generic] industry is $3.97B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

LOVFF’s FA Score shows that 0 FA rating(s) are green whileTSMRF’s FA Score has 2 green FA rating(s).

  • LOVFF’s FA Score: 0 green, 5 red.
  • TSMRF’s FA Score: 2 green, 3 red.
According to our system of comparison, TSMRF is a better buy in the long-term than LOVFF.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

LOVFF’s TA Score shows that 5 TA indicator(s) are bullish while TSMRF’s TA Score has 2 bullish TA indicator(s).

  • LOVFF’s TA Score: 5 bullish, 5 bearish.
  • TSMRF’s TA Score: 2 bullish, 1 bearish.
According to our system of comparison, TSMRF is a better buy in the short-term than LOVFF.

Price Growth

LOVFF (@Pharmaceuticals: Generic) experienced а +5.91% price change this week, while TSMRF (@Pharmaceuticals: Generic) price change was 0.00% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Generic industry was +3.81%. For the same industry, the average monthly price growth was +6.75%, and the average quarterly price growth was +54.33%.

Industries' Descriptions

@Pharmaceuticals: Generic (+3.81% weekly)

A generic drug contains the same chemical substance as a drug that was originally protected by patents. Generic drugs are generally sold at cheaper price points, compared to name-brand pharmaceuticals, after patents for the more expensive drugs lapse. The generic drug industry has created a major market, thanks to the lower pricing. According to the Center for Justice and Democracy at New York Law School, 80 percent of all drugs prescribed are generic, and generic drugs are chosen 94 percent of the time when they are available. But their manufacturers must be able to prove to the FDA that they can be effective substitutes for the original drugs. Some of the major generic drug makers include Zoetis, Inc., Allergan plc and Mylan N.V.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
TSMRF($1.79B) has a higher market cap than LOVFF($118M). LOVFF has higher P/E ratio than TSMRF: LOVFF (10.60) vs TSMRF (8.04). LOVFF YTD gains are higher at: 150.729 vs. TSMRF (-17.584). TSMRF has higher annual earnings (EBITDA): 47.8B vs. LOVFF (27M). TSMRF has more cash in the bank: 82.4B vs. LOVFF (14.4M). LOVFF has less debt than TSMRF: LOVFF (47.5M) vs TSMRF (71.4B). TSMRF has higher revenues than LOVFF: TSMRF (165B) vs LOVFF (102M).
LOVFFTSMRFLOVFF / TSMRF
Capitalization118M1.79B7%
EBITDA27M47.8B0%
Gain YTD150.729-17.584-857%
P/E Ratio10.608.04132%
Revenue102M165B0%
Total Cash14.4M82.4B0%
Total Debt47.5M71.4B0%
FUNDAMENTALS RATINGS
LOVFF vs TSMRF: Fundamental Ratings
LOVFF
TSMRF
OUTLOOK RATING
1..100
9147
VALUATION
overvalued / fair valued / undervalued
1..100
54
Fair valued
6
Undervalued
PROFIT vs RISK RATING
1..100
62100
SMR RATING
1..100
5131
PRICE GROWTH RATING
1..100
3977
P/E GROWTH RATING
1..100
6892
SEASONALITY SCORE
1..100
7530

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TSMRF's Valuation (6) in the null industry is somewhat better than the same rating for LOVFF (54). This means that TSMRF’s stock grew somewhat faster than LOVFF’s over the last 12 months.

LOVFF's Profit vs Risk Rating (62) in the null industry is somewhat better than the same rating for TSMRF (100). This means that LOVFF’s stock grew somewhat faster than TSMRF’s over the last 12 months.

TSMRF's SMR Rating (31) in the null industry is in the same range as LOVFF (51). This means that TSMRF’s stock grew similarly to LOVFF’s over the last 12 months.

LOVFF's Price Growth Rating (39) in the null industry is somewhat better than the same rating for TSMRF (77). This means that LOVFF’s stock grew somewhat faster than TSMRF’s over the last 12 months.

LOVFF's P/E Growth Rating (68) in the null industry is in the same range as TSMRF (92). This means that LOVFF’s stock grew similarly to TSMRF’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
LOVFFTSMRF
RSI
ODDS (%)
Bullish Trend 2 days ago
69%
N/A
Stochastic
ODDS (%)
Bearish Trend 2 days ago
82%
N/A
Momentum
ODDS (%)
Bullish Trend 2 days ago
66%
Bullish Trend 2 days ago
18%
MACD
ODDS (%)
Bullish Trend 2 days ago
73%
Bullish Trend 2 days ago
23%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
69%
Bullish Trend 2 days ago
14%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
66%
Bullish Trend 2 days ago
12%
Advances
ODDS (%)
Bullish Trend 16 days ago
74%
N/A
Declines
ODDS (%)
Bearish Trend 9 days ago
74%
N/A
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
79%
N/A
Aroon
ODDS (%)
Bearish Trend 2 days ago
77%
Bearish Trend 2 days ago
14%
View a ticker or compare two or three
Interact to see
Advertisement
LOVFF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
TSMRF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
HFCVX22.95N/A
N/A
Hennessy Cornerstone Value Investor
VCGEX7.79N/A
N/A
VALIC Company I Emerg Economies
LIACX12.22N/A
N/A
Columbia Acorn C
OTCAX30.94N/A
N/A
MFS Mid Cap Growth A
CVAIX25.22-0.02
-0.08%
Calamos Select Fund I

LOVFF and

Correlation & Price change

A.I.dvisor tells us that LOVFF and VPHIF have been poorly correlated (+17% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that LOVFF and VPHIF's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To LOVFF
1D Price
Change %
LOVFF100%
-0.31%
VPHIF - LOVFF
17%
Poorly correlated
N/A
KKPCF - LOVFF
6%
Poorly correlated
N/A
VTRS - LOVFF
3%
Poorly correlated
+0.79%
VEXTF - LOVFF
1%
Poorly correlated
+0.08%
GEDSF - LOVFF
-0%
Poorly correlated
N/A
More

TSMRF and

Correlation & Price change

A.I.dvisor tells us that TSMRF and TKPHF have been poorly correlated (+-0% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that TSMRF and TKPHF's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To TSMRF
1D Price
Change %
TSMRF100%
N/A
TKPHF - TSMRF
-0%
Poorly correlated
N/A
TCNNF - TSMRF
-1%
Poorly correlated
-1.49%
TEVJF - TSMRF
-1%
Poorly correlated
N/A
VEXTF - TSMRF
-4%
Poorly correlated
+0.08%
LOVFF - TSMRF
-5%
Poorly correlated
-0.31%
More